UnitedHealth and other major insurers saw their recent momentum stall, surrendering a portion of their weekly gains. Despite this dip, these stocks managed to hold onto positive territory for the week, signaling continued confidence in their underlying financial stability. Meanwhile, the pharmaceutical giants Pfizer and Merck bucked the downward trend, climbing in anticipation of upcoming quarterly earnings reports that could provide a clearer picture of sector health.
Defensive Rotation Cushions Health Sector Against Market Slide
Investors pivoted away from technology stocks on Thursday, seeking shelter in the healthcare sector as broader market benchmarks retreated. While the industry did not escape the day’s selling pressure entirely, it outperformed major indices by maintaining a defensive posture that favored established pharmaceutical firms over high-growth volatility.
When reusing this material a link to Money Talk is required.
Comments (0)
No comments yet. Be the first!